Clinical Trial Update: A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839 [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial in Singapore evaluated the combination of celecoxib and gefitinib for nasopharyngeal carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Celecoxib (Celecoxib)
• Gefitinib (Gefitinib)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Nasopharyngeal Carcinoma | Phase 1, Phase 2 | Status: COMPLETED